With our continuous quest for scientific excellence, CrownBio needs the guidance and experience from thought leaders in the drug discovery field. Our high powered Scientific Advisory Board consists of leaders and scientists who have spent their entire careers devoted to cancer or diabetes drug discovery, exploited mechanisms of drug resistance, driven over 25 investigational drugs to clinical trials, and successfully had 6 drugs approved for the treatment of cancer by worldwide regulatory agencies.
- Homer Pearce, PhD (Chair) - Ex VP Oncology, Eli Lilly & Co.
- Melanie Cobb, PhD - Dean, UT Southwestern, Graduate School of Biomedical Research
- Sara Courtneidge, PhD - Professor Burnham Institute/Ex CSO Sugen
- Steve Kaldor, PhD - Partner, Versant Ventures